---
title: "European Equities Traded in the US as ADRs Rise in Tuesday Trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282717218.md"
description: "European equities traded in the US saw a rise in American depositary receipts, with the S&P Europe Select ADR Index increasing by 0.3% to 1,844.78. Notable gainers included Grifols (3.1%) and Opera (2.9%), while decliners included Equinor (-2.5%) and Evaxion (-1.2%). In the UK, Bicycle Therapeutics led with a 6.2% increase, while Trinity Biotech fell by 1.7%."
datetime: "2026-04-14T15:05:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282717218.md)
  - [en](https://longbridge.com/en/news/282717218.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282717218.md)
---

# European Equities Traded in the US as ADRs Rise in Tuesday Trading

11:05 AM EDT, 04/14/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts rose late Tuesday morning with the S&P Europe Select ADR Index gaining 0.3% to 1,844.78.

From continental Europe, the gainers were led by biopharmaceutical company Grifols ( GRFS ) and internet browser company Opera (OPRA), which rose 3.1% and 2.9%, respectively. They were followed by pharmaceutical company Novo Nordisk ( NVO ) and semiconductor company Sequans Communications ( SQNS ) , which were up 2.3% and 1.6%, respectively.

The decliners from continental Europe were led by petroleum refiner Equinor ( EQNR ) and biotech firm Evaxion ( EVAX ) , which fell 2.5% and 1.2%, respectively. They were followed by oil and gas company Eni (E) and pharmaceutical company Ascendis Pharma ( ASND ) , which were down 1% and 0.5%, respectively.

The gainers from the UK were led by biopharmaceutical companies Bicycle Therapeutics ( BCYC ) and Biodexa Pharmaceuticals ( BDRX ) , which advanced 6.2% and 4.2%, respectively. They were followed by biopharmaceutical company NuCana ( NCNA ) and cruise line operator Carnival (CUK), which increased 3.4% and 3%, respectively.

The decliners from the UK and Ireland were led by biotech firm Trinity Biotech ( TRIB ) and pharmaceutical company Silence Therapeutics ( SLN ) , which dropped 1.7% and 1.5%, respectively. They were followed by tobacco company British American Tobacco ( BTI ) and oil and gas company Shell (SHEL), which were off 1.4% and 1.1%, respectively.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

### Related Stocks

- [OPRA.US](https://longbridge.com/en/quote/OPRA.US.md)
- [EVAX.US](https://longbridge.com/en/quote/EVAX.US.md)
- [BCYC.US](https://longbridge.com/en/quote/BCYC.US.md)
- [GRFS.US](https://longbridge.com/en/quote/GRFS.US.md)
- [IEV.US](https://longbridge.com/en/quote/IEV.US.md)

## Related News & Research

- [Grifols Calls June 2026 Shareholders’ Meeting With Broad Capital and Governance Mandate](https://longbridge.com/en/news/286598481.md)
- [Bicycle Therapeutics Q1 revenue drops after partnership terminations](https://longbridge.com/en/news/284755904.md)
- [20:00 ETLOTTE Biologics Expands Antibody Manufacturing Agreement with Ottimo Pharma](https://longbridge.com/en/news/286687690.md)
- [What Madrigal Pharmaceuticals (MDGL)'s Wider Q1 Losses and Rezdiffra Revenue Momentum Mean For Shareholders](https://longbridge.com/en/news/286674743.md)
- [Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors | IMUX Stock News](https://longbridge.com/en/news/286894992.md)